Position in SUPN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$587,838
-$65,471 QoQ
Shares Held
12,639
0.0% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#174
of 331 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026COMMERCE BANK holds $12,369,158 across 9 Drug Manufacturers - Specialty & Generic names. SUPN ranks #7 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
54,446 | $3,912,489 | |
| 2 | VTRS |
Viatris Inc
|
151,250 | $2,401,850 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
13,249 | $2,232,985 | |
| 4 | HROW |
Harrow, Inc.
|
22,430 | $952,602 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
37,614 | $925,680 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,447 | $784,027 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
12,639 | $587,838 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
38,310 | $383,100 |
All Filings in SUPN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $587,838 | 12,639 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $653,309 | 12,639 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $662,550 | 13,331 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $676,228 | 14,150 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $476,739 | 15,125 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $492,068 | 15,025 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $481,108 | 13,305 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $421,865 | 13,530 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $370,085 | 13,835 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $471,910 | 13,835 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $415,143 | 14,345 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $400,233 | 14,517 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $442,633 | 14,725 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $539,826 | 14,900 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $551,992 | 15,475 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $667,183 | 19,710 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $570,012 | 19,710 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $637,026 | 19,710 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $598,508 | 20,525 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $466,590 | 17,495 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $579,313 | 18,815 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $494,146 | 18,875 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $336,011 | 13,355 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $282,069 | 13,535 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $225,387 | 9,490 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||